Gilead Dives As Its Biggest Moneymaker Misses. Here's Why It Could Still Be A 'Safe Haven' Stock.
In This Article:
Two of Gilead Sciences' most important drugs missed sales expectations late Thursday. Gilead stock fell early Friday.
Terms and Privacy Policy